BMJ: ‘Adding a sulfonylurea to metformin looks safer than switching to one’

BMJ: ‘Adding a sulfonylurea to metformin looks safer than switching to one’

July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk...

Effect of omega-3 or other fatty acids on heart disease is negligible finds Cochrane review

Effect of omega-3 or other fatty acids on heart disease is negligible finds Cochrane review

July 19 2018 Cochrane researchers have published research indicating that omega 3 supplements...

DOACs associated with reduced risk of major bleeding compared to warfarin

DOACs associated with reduced risk of major bleeding compared to warfarin

July 11 2018 Direct oral anticoagulants (DOACs) have been associated with reduced risks of major...

Recorded penicillin allergy associated with increased risk of MRSA and C difficile

Recorded penicillin allergy associated with increased risk of MRSA and C difficile

July 3 2018 People who have a record of penicillin allergy are at an increased risk of developing...

MPS advises of need for better awareness of cauda equina red flag symptoms

MPS advises of need for better awareness of cauda equina red flag symptoms

May 9 2018 The Medical Protection Society is advising doctors of a revision to the NICE Clinical...

  • BMJ: ‘Adding a sulfonylurea to metformin looks safer than switching to one’

    BMJ: ‘Adding a sulfonylurea to metformin looks safer than switching to one’

    Wednesday, 25 July 2018 14:07
  • Effect of omega-3 or other fatty acids on heart disease is negligible finds Cochrane review

    Effect of omega-3 or other fatty acids on heart disease is negligible finds Cochrane review

    Thursday, 19 July 2018 10:36
  • DOACs associated with reduced risk of major bleeding compared to warfarin

    DOACs associated with reduced risk of major bleeding compared to warfarin

    Wednesday, 11 July 2018 13:22
  • Recorded penicillin allergy associated with increased risk of MRSA and C difficile

    Recorded penicillin allergy associated with increased risk of MRSA and C difficile

    Tuesday, 03 July 2018 16:51
  • MPS advises of need for better awareness of cauda equina red flag symptoms

    MPS advises of need for better awareness of cauda equina red flag symptoms

    Wednesday, 09 May 2018 16:01

a blood pressure monitor imageJuly 11 2018

Community pharmacy referrals for hypertensive patients under the New Medicines Service has not increased GP workload appreciably.


Analysis of 131,419 patient records in England has found that 4.5% of patients were referred by a pharmacist to a GP within the first 2 weeks of starting a new antihypertensive medication. The patients most commonly referred to the GP were those experiencing side effects, but other significant influences on referral were medication-related concerns and the drug class.

In terms of drug class, the introduction of an alpha blocker into the patient’s therapy was most likely to result in a referral, while patients prescribed angiotensin-II receptor blockers were least likely to be referred. 

The findings have been published in the British Journal of General Practice, with the researchers looking at data relating to the introduction of the New Medicines Service in 2011-12. It found that the mean age of patients assessed under the NMS was 65 years.

“These data are reassuring, in that additional pharmacist involvement does not increase medical workload appreciably, and support further development of pharmacist-led hypertension interventions,” said the researchers from the Nuffield Department of Primary Care Health Sciences, University of Oxford.

“The impact on clinical workload of additional pharmacy services is worthy of consideration. With the incidence of new hypertension cases at eight people per 1,000, a 4% referral rate would mean that of the 52 new hypertension cases per practice per year only two would need to be seen again by their GP within two weeks of medication initiation. 

“Without knowing the rate of patient re-presentation to GPs outside of the NMS, it is difficult to determine whether a 4% referral rate would indeed represent an improvement or worsening of the current situation; however, these numbers appear low.”

Link:
A Albrasi et al. ‘Hypertension referrals from community pharmacy to general practice: multivariate logistic regression analysis of 131 419 patients’. Br J Gen Pract 5 July 2018; bjgp18X697925.        

Clinical News

July 27 2018 Adolescent boys will be offered the human papilloma virus (HPV) vaccine to protect them from cancer, the Department of Health and Social Care has announced.
July 20 2018 Doctors are being reminded to ensure that any patient or other records which may be relevant to the UK Infected Blood Inquiry are not destroyed. Earlier this month, the Inquiry’s Chair, Sir...